Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence. - Wikidata - awgldk - TriplyDB

Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence.

Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence.

http://www.wikidata.org/entity/Q34753286

about

Role of HLA Adaptation in HIV Evolution Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana The impact of host genetic variation on infection with HIV-1.Recent advances in understanding HIV evolution Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection.HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses.Rapid HIV-1 Disease Progression in Individuals Infected with a Virus Adapted to Its Host Population.New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon Effects of contact structure on the transient evolution of HIV virulence.The impact of antiretroviral therapy on population-level virulence evolution of HIV-1 Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic The adaptive evolution of virulence: a review of theoretical predictions and empirical tests Impact of pre-adapted HIV transmission.Prospects for HIV control in South Africa: a model-based analysis.Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02 A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda.Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection.Modelling the evolution of HIV-1 virulence in response to imperfect therapy and prophylaxis Exploring the role of the α-carboxyphosphonate moiety in the HIV-RT activity of α-carboxy nucleoside phosphonates HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients.Host genetic variation and HIV disease: from mapping to mechanism.HLA-B*14:02-Restricted Env-Specific CD8+ T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection.Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression.A trend towards increasing viral load in newly diagnosed HIV-infected inpatients in southeast China.Role of HIV-specific CD8(+) T cells in pediatric HIV cure strategies after widespread early viral escape.In vivo virulence of MHC-adapted AIDS virus serially-passaged through MHC-mismatched hosts.Reply to Jefferys: Declining HIV virulence.Evidence for HIV weakening over time.Detecting signatures of past pathogen selection on human HLA loci: are there needles in the haystack?Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations.Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death.Evolution of HIV virulence in response to widespread scale up of antiretroviral therapy: a modeling study.Modelling coevolution in ecological networks with adaptive dynamics Extensive host immune adaptation in a concentrated North American HIV epidemic

P2860

Q26772713-35B3D1E7-78CC-431F-B2BF-C216492FD10B Q28546809-68CFC680-64E7-4418-9177-014DB7B6E05B Q30374810-078C043E-A042-44C0-BC3D-4AE5A3371926 Q33631993-2F77E98F-71D4-4910-879C-95A28FCC13EC Q33788085-8E1F77FB-3653-4DFD-83E8-35A0F75721D6 Q35188022-ED6AA2DD-EEDB-4C57-AB93-E1D37637836E Q35664125-EC6BF419-6D4D-4D0F-AF18-830625C74DB7 Q35753766-4E9040C7-DECD-4D64-B9BD-CE5007F20AED Q35949014-CA6C13EF-2C6C-47A3-AB73-249C5B85FBEE Q36089497-1DAF4CCF-88A4-4280-A7AB-962188821600 Q36329987-BE1196D0-C46F-4BC3-BF4A-45DB711F6C66 Q36449841-9FC7E212-931E-47D4-B934-456933FDE638 Q36481449-5FAE179E-43F2-4CC6-96CB-3B2AB7A1A350 Q36919489-ABF34D54-853D-4EB7-8E0D-352B806CE29B Q36984267-37721D14-D255-4E41-829C-AB53A6DCEB47 Q36991363-C23157A5-5966-43AF-9922-45B916C999EF Q37074610-9C507EEA-0835-4F01-8F9E-3C8BD4C63302 Q37423475-A7ED35E2-5752-45F5-9A3E-58D1C18658B2 Q37613230-3FE94F15-2CEA-4605-9195-15EC7271478D Q37661125-808D32AE-8B98-4120-A0BF-C6E4A8EB2707 Q38514586-D903B8D9-D711-4219-9061-918E9CC552DC Q38644772-3C639343-6434-419A-B2F7-9231E88A3D1E Q39427526-B23DA209-F01A-40FC-82C9-101E4FA2C168 Q40054946-54789FF5-48C1-415A-B43E-204AF1FFDB16 Q40349815-312D8500-B1C2-4019-8B43-EC420E2723A2 Q40844725-63ACD11C-5C51-415C-AF2E-1FA880A47CF0 Q41923263-9908FCA2-FCEF-440C-B41D-3C8E1274E36F Q41933652-61F59905-7059-4169-BAD9-28630BDC2375 Q42575565-9C88817E-4626-41BF-88CE-7DB759460625 Q42575599-7236756F-8261-4103-A4ED-419C449A8C52 Q46320975-ECFD7935-71C9-479B-A8E3-CFC9F8E230CA Q46461115-067A2714-5002-472D-A799-88E147CBA9A4 Q47099267-90576544-02FD-44B3-A0E3-743204355EF7 Q52807240-DEB5C8E2-940C-4940-9C50-3D0E827A56F0 Q53750601-DBBC79B9-7B6E-4889-BB24-F5738E564C06 Q57032432-154699FA-5D28-43C4-A468-03B2EB5B9B4D Q58767928-54BD2B7C-440F-45C9-A0A9-342F0F2D6C7B

P2860

Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence.

http://www.wikidata.org/entity/Q34753286

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Impact of HLA-driven HIV adapt ...... ns of high HIV seroprevalence.

@ast

Impact of HLA-driven HIV adapt ...... ns of high HIV seroprevalence.

@en

Impact of HLA-driven HIV adapt ...... ns of high HIV seroprevalence.

@nl

type

label

Impact of HLA-driven HIV adapt ...... ns of high HIV seroprevalence.

@ast

Impact of HLA-driven HIV adapt ...... ns of high HIV seroprevalence.

@en

Impact of HLA-driven HIV adapt ...... ns of high HIV seroprevalence.

@nl

prefLabel

Impact of HLA-driven HIV adapt ...... ns of high HIV seroprevalence.

@ast

Impact of HLA-driven HIV adapt ...... ns of high HIV seroprevalence.

@en

Impact of HLA-driven HIV adapt ...... ns of high HIV seroprevalence.

@nl

P1433

Q34753286-22C9D222-944B-4442-84E9-DC49A4CFCECF

P1476

Q34753286-DCAE0719-8B6E-490D-B9C8-6C2EAAFC337B

P2093

Q34753286-37E93125-2EF1-4BCA-8560-B34DFDBB51BD

Q34753286-384B1421-EA13-4DF1-B582-0A665DF7A722

Q34753286-41C7CAD4-0495-4C2B-8E59-0860B93ACE77

Q34753286-5099059A-0C90-46E0-9CC0-A2470DB4EF27

Q34753286-588A46F1-E759-4776-94C6-0B57480E83A0

Q34753286-961EF9EA-4018-41D2-B2C4-A3039A99537F

Q34753286-992B94D1-3553-4A2E-986A-2F674931F962

Q34753286-CB644137-8774-44B1-A931-D6EC372405FD

Q34753286-DF80E293-8382-420A-A1F7-5AD916750A4C

P2860

Q34753286-00DD5B68-BD7E-4689-8F57-047BA29EE30F

Q34753286-0FE1CA42-1DD4-4811-B58A-F01F686003D3

Q34753286-11A1B007-510A-4B72-9511-0BC7CDC285F6

Q34753286-13BB6680-47AB-48A5-A937-89223A43BD29

Q34753286-1EDE6F5D-84D2-4797-8E62-F44A79D84E54

Q34753286-21801A3A-C9E8-420A-88E8-B6D7C2CFB508

Q34753286-219E7411-EE04-44D3-9783-2EF260DFCF82

Q34753286-237D8431-49FC-47E4-B968-28D70352DFBF

Q34753286-248264BC-BFF8-4D64-9566-96E6D8411F7C

Q34753286-262F58A7-1B9C-4625-9095-DBF37A9F4427

P304

Q34753286-638BB50D-291C-457C-94B0-088900CC7E8B

P31

Q34753286-8409964F-4C8D-47F3-B74C-B1BACB77AF40

P356

Q34753286-F7FDA411-9755-4E15-9F84-413CDB20EDBC

P407

Q34753286-BFCD7AAA-A8EB-4A75-B81D-45952078E35F

P433

Q34753286-0ADE5DC4-F2CC-4AF8-8729-10D5D589ECB4

P478

Q34753286-830EAA3C-2972-48DD-951C-B2082BF8DA4B

P50

Q34753286-21FBB14E-1145-4FFD-8298-17EBF16FADDD

Q34753286-22C2DC68-90D1-4A74-A204-26D34C1ED485

Q34753286-23208AA7-1782-46B3-B860-B06E63EB25E9

Q34753286-3BDDAEA1-FE1B-4126-A96A-3AB0755DE851

Q34753286-543B50EE-129A-4C96-8B28-676A210CE935

Q34753286-83392635-E56C-4BD5-AAF0-3F602978D081

Q34753286-8D24F2FF-0150-4A20-A8DC-54133392985A

Q34753286-90912F26-56A0-4B76-AA43-868607C753DE

Q34753286-91A9FA83-4458-46C4-80EE-DE6B6A5D806A

Q34753286-E1B30600-D3D5-4093-99F4-9E2AB4323049

P577

Q34753286-BFF735B7-BB47-41DD-A6A4-3F74986B5165

P5875

Q34753286-44C8C54A-E984-4AE9-91DF-568D52867E14

P698

Q34753286-F241B23A-6BF9-48E8-A133-EE2F1E29DCB3

P921

Q34753286-D7D1603E-8330-4238-9DC5-E6FDB3C72A2A

P932

Q34753286-73161387-5F50-428C-B0E8-4A603F01690C

P356

PNAS.1413339111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Impact of HLA-driven HIV adapt ...... ns of high HIV seroprevalence.

@en

P2093

Allison Hempenstall

http://www.w3.org/2001/XMLSchema#string

Angela R McLean

http://www.w3.org/2001/XMLSchema#string

Jaclyn Mann

http://www.w3.org/2001/XMLSchema#string

Jonathan M Carlson

http://www.w3.org/2001/XMLSchema#string

Marc Sinclair

http://www.w3.org/2001/XMLSchema#string

Maximilian Muenchhoff

http://www.w3.org/2001/XMLSchema#string

Myron Essex

http://www.w3.org/2001/XMLSchema#string

Roger Shapiro

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Miura

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of HIV-1 infection with early antiretroviral therapy

Statistical significance for genomewide studies

New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0

HyPhy: hypothesis testing using phylogenies

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

The Leeuwenhoek Lecture 2001. Animal origins of human infectious disease.

Modelling the evolution and spread of HIV immune escape mutants

Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag.

Replicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rate

P304

E5393-400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1413339111

http://www.w3.org/2001/XMLSchema#string

P407

P433

50

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Bruce D. Walker

Mark A. Brockman

Philippa C Matthews

Zabrina L Brumme

Hannah E Roberts

Philip J. R. Goulder

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269171202

http://www.w3.org/2001/XMLSchema#string

P698

25453107

http://www.w3.org/2001/XMLSchema#string

P921

P932

4273423

http://www.w3.org/2001/XMLSchema#string